CLDN18.2 chimeric antigen receptor T cell therapy for patients with advanced gastric and pancreatic adenocarcinoma: Results of ELIMYN18.2 phase 1b clinical trial Meeting Abstract
| Authors: | Botta, G. P.; Kelly, R. J.; Jin, Z.; Ma, H.; Ku, G. Y.; Zhao, D.; Mehta, R.; Carnevale, J. C.; Sierra, G.; Jia, J.; Baffa, R.; Li, Z.; Kim, D. W.; Yoon, H. H. |
| Abstract Title: | CLDN18.2 chimeric antigen receptor T cell therapy for patients with advanced gastric and pancreatic adenocarcinoma: Results of ELIMYN18.2 phase 1b clinical trial |
| Meeting Title: | 2024 ASCO Gastrointestinal Cancers Symposium |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 42 |
| Issue: | 3 Suppl. |
| Meeting Dates: | 2024 Jan 18-20 |
| Meeting Location: | San Francisco, CA |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2024-01-20 |
| Language: | English |
| ACCESSION: | WOS:001266680500672 |
| DOI: | 10.1200/JCO.2024.42.3_suppl.356 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 356 -- Source: Wos |
